Friday, March 6, 2009

University of Mesothelioma

mesothelioma attorney help (video)

Action Mesothelioma Day Friday 27th February 2009

Action Mesothelioma Day Friday 27th February 2009 • To raise awareness about the dangers of exposure to asbestos • To raise issues facing victims of Mesothelioma (asbestos related cancer) 10.30am–12.30pm – Meeting in Cinema 1, The QUAD, Market Place, Cathedral Quarter, Derby, DE1 3AS. Registration from 10.00am Speakers include • Dave Fisher, Solicitor from Rowley Ashworth Solicitors • Adrian Axtell, Unite the Union • Michael Lees (campaigner on asbestos in schools) • Sarah Avery, Lung Cancer Nurse Specialist from Glenfield Hospital • Roger McKenzie, Midlands TUC • Mrs Carol Anthony and Mrs Pepper – DAST members and supporters Proceed to Market Place 12.30pm – short performance from Theatre Company Babbling Vagabonds to raise awareness about the dangers of exposure to asbestos 12.45 – Lunch Derbyshire Asbestos Support Team (DAST) on 01623 748161 Charity number 1119684 Action Mesothelioma Day 2009 I would like to sponsor a message for Action Mesothelioma Day Name…………………………………………………….. Address…………………………………………………………………………… ………………………………………………………………………………………. ……………………………………………………………………………………….. Message (no more than 4 to 5 lines) message can remember a loved one made ill or who has died from mesothelioma. You can also send a photograph. Or the message can be about raising awareness of the dangers of exposure to asbestos or hopes of finding a cure. (Anything you like). Donation (Suggested minimum £2.00) £………………………………. Please make cheques payable to ‘Derbyshire Asbestos Support Team’. When all donations have been received we will send a cheque to the June Hancock Mesothelioma Research Fund and the Mick Knighton Mesothelioma Research Fund. Please return to Joanne Carlin, DAST, 44 Patchwork Row, Shirebrook, Mansfield, Notts, NG20 8AL. Phone: 01623 748161

important info on mesothelioma

Mesothelioma is fairly rare. there's an estimated 2,000 to 3,000 new cases per year of mesothelioma in the United States, but this figure appears to be increasing.
The average age at diagnosis is 50 to 70 years old. The disease affects men 3 to 5 times more often than women. Mesothelioma is less common in African Americans than in Caucasians.
The 5-year survival rate refers to the percent of patients who live at least 5 years after their cancer is diagnosed. lots of of these patients live much longer than 5 years after diagnosis, & 5-year rates are used to produce a standard way of discussing prognosis. Five-year relative survival rates exclude from the calculations patients dying of other diseases, & are considered to be a more accurate way to explain the prognosis for patients with a particular type & stage of cancer. Of course, 5-year survival rates are based on patients diagnosed & initially treated over 5 years ago. Improvements in treatment often result in a more favorable outlook for recently diagnosed patients
Mesothelioma is a serious disease. By the time the symptoms appear & cancer is diagnosed, the disease is often advanced. The average survival time is about five year. However, if the cancer is found early & treated aggressively, half of the patients whose cancer is found early reach the two-year mark, & about 20% survive four years.

Good news (mesothelioma new drug tested)

Recently a new drug, Vinflunine ,has emerged as an exciting new treatment option for Pleural Mesothelioma patients. Testing of this drug were done on sixty-seven Pleural Mesothelioma patients who had not received radiation or chemotherapy as forms of treatment for their disease. Vinflunine was administered via intravenous infusion 320 mg/m2 for a one of twenty day cycle. In conclusion, Vinflunine achieved a 13.8% response rate, which may seem small, but is significant, since current Mesothelioma treatments much to be desired.
Mesothelioma is an incurable cancer that effects the lining of the lungs. Mesothelioma is a cancer caused by exposure to asbestos. one of this diseases characteristics is that it is currently incurable. Treatment is limited to chemotherapy, surgery, immunotherapy, and radiation all of which have not proved successful.
With further research and the emergence of new drugs like Vinflunine, Mesothelioma should have better treatment options in the near future